Role of the B‐cell response in recovery of mice from primary influenza virus infection

Recovery from influenza virus infection has long been known to require an intact T‐cell compartment. More recent studies revealed that CD8 and CD4Tcells can promote recovery through independent mechanisms. The CD4 T‐cell‐dependent recovery process appears to operate primarily through promotion of the T‐dependent antibody response as B‐cell‐deficient μMT mice cannot recover from infection if they have been depleted of CDS T cells. The potential therapeutic activity of the B‐cell response was further studied by transfer of antibodies into infected SCID mice. At the dose of 200 μg/mouse. most antibodies (of IgG2a isotype) to the viral transmembrane protein HA cured the infection, while those to the transmembrane proteins NA and M2 suppressed virus titers in the lung but failed to clear the infection. The ability of passive antibody to resolve the‐infection was closely related to its prophylactic activity, suggesting that neutralization of progeny virus (VN) played an important role in the process of virus clearance in vivo, while reaction of antibodies with infected host cells contributed to but was insufficient, on its own for cure. HA‐specific antibodies of IgM and IgA isotypes were therapeutically ineffective against pulmonary infection, presumably because of a preferential delivery into the upper respiratory tract, while IgG exhibited highest activity against pulmonary and minimal activity against nasal infection. B cells appear to be of similar importance for recovery from primary infection as CDS T cells.

[1]  K. Mozdzanowska,et al.  A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro , 1997, Journal of virology.

[2]  R. Zinkernagel,et al.  Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Zinkernagel,et al.  The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. , 1996, Immunity.

[4]  A. Kelso,et al.  Functionally distinct T cells in three compartments of the respiratory tract after influenza virus infection , 1996, European journal of immunology.

[5]  D. Ernst,et al.  CD4+ T cell activation and tolerance induction in B cell knockout mice , 1996, The Journal of experimental medicine.

[6]  P. Doherty,et al.  Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium , 1996, Journal of virology.

[7]  W. Liles,et al.  Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. , 1995, The Journal of infectious diseases.

[8]  J. West,et al.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.

[9]  A. Sher,et al.  Successful T Cell Priming in B Cell-deficient Mice , 1995 .

[10]  R. Webster,et al.  The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin , 1995, Journal of virology.

[11]  Y. Wu,et al.  Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. , 1995, International immunology.

[12]  K. Mozdzanowska,et al.  Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice , 1995, Journal of virology.

[13]  P. Doherty,et al.  Clearance of Sendai virus by CD8+ T cells requires direct targeting to virus‐infected epithelium , 1995, European journal of immunology.

[14]  M. Graham,et al.  Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection , 1994, The Journal of experimental medicine.

[15]  H. Klenk,et al.  Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry. , 1994, Virology.

[16]  R. Coffman,et al.  Administration of anti-IFN-gamma antibody to beta 2-microglobulin-deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. , 1994, Journal of immunology.

[17]  R M Zinkernagel,et al.  How many specific B cells are needed to protect against a virus? , 1994, Journal of immunology.

[18]  M. Ogimoto,et al.  Negative regulation of apoptotic death in immature B cells by CD45. , 1994, International immunology.

[19]  K. Mozdzanowska,et al.  Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. , 1994, Journal of immunology.

[20]  F. Alt,et al.  Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. , 1993, International immunology.

[21]  A. Ramsay,et al.  A case for cytokines as effector molecules in the resolution of virus infection. , 1993, Immunology today.

[22]  R. Zinkernagel,et al.  T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. , 1993, Journal of immunology.

[23]  W. Allan,et al.  Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia , 1993, The Journal of experimental medicine.

[24]  T. Croghan,et al.  Transgenic mice lacking class I major histocompatibility complex- restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge , 1992, The Journal of experimental medicine.

[25]  P. Scherle,et al.  Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. , 1992, Journal of immunology.

[26]  L. Staudt,et al.  A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response , 1991, European journal of immunology.

[27]  R. Jaenisch,et al.  Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells , 1991, The Journal of experimental medicine.

[28]  R. Webster,et al.  Influenza virus RNA in the lung and lymphoid tissue of immunologically intact and CD4-depleted mice. , 1991, The Journal of general virology.

[29]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[30]  P. Small,et al.  Immunoglobulin A mediation of murine nasal anti-influenza virus immunity , 1991, Journal of Virology.

[31]  L. Staudt,et al.  A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. , 1990, Journal of immunology.

[32]  P. Doherty,et al.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. , 1990, Journal of immunology.

[33]  E. Paoletti,et al.  Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. , 1990, The Journal of general virology.

[34]  B. Askonas,et al.  Murine CD4+ T cell clones vary in function in vitro and in influenza infection in vivo , 1990, International immunology.

[35]  R. Lamb,et al.  Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice , 1990, Journal of virology.

[36]  B. Askonas,et al.  Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. , 1989, Immunology.

[37]  R. Ramphal,et al.  Passive serum antibody causes temporary recovery from influenza virus infection of the nose, trachea and lung of nude mice. , 1988, Immunology.

[38]  T. Kipps,et al.  Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody. , 1987, Journal of immunology.

[39]  H. Waldmann,et al.  Do L3T4+ T cells act as effector cells in protection against influenza virus infection. , 1987, Immunology.

[40]  R. Levy,et al.  Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. , 1986, Journal of immunology.

[41]  I. Bernstein,et al.  Influence of antibody isotype on passive serotherapy of lymphoma. , 1985, Journal of immunology.

[42]  R. Chanock,et al.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats , 1985, Journal of virology.

[43]  T. Braciale,et al.  In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific , 1984, The Journal of experimental medicine.

[44]  Y. Zee,et al.  Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus , 1981, Infection and immunity.

[45]  J. Yewdell,et al.  Expression of influenza A virus internal antigens on the surface of infected P815 cells. , 1981, Journal of immunology.

[46]  F. Ennis,et al.  Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. , 1981, Journal of immunology.

[47]  C. Sweet,et al.  Pathogenicity of influenza virus , 1980, Microbiological reviews.

[48]  R. Webster,et al.  Monoclonal antibodies to influenza matrix protein: detection of low levels of matrix protein on abortively infected cells. , 1980, The Journal of general virology.

[49]  R. Ramphal,et al.  Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis , 1979, Infection and immunity.

[50]  G. Ada,et al.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus , 1978, Nature.

[51]  J. Schulman,et al.  Effects of cell mediated immunity in influenza virus infection in mice. , 1977, Developments in biological standardization.

[52]  J. Oxford,et al.  Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells , 1977, Nature.

[53]  T. Iwasaki,et al.  Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. , 1977, Journal of immunology.

[54]  J. Virelizier,et al.  Host defenses against influenza virus: the role of anti-hemagglutinin antibody. , 1975, Journal of immunology.

[55]  M. Eichelberger,et al.  Roles of alpha beta and gamma delta T cell subsets in viral immunity. , 1992, Annual review of immunology.

[56]  B. Murphy,et al.  The systemic and mucosal immune response of humans to influenza A virus. , 1989, Current topics in microbiology and immunology.

[57]  P. Brandtzaeg Overview of the mucosal immune system. , 1989, Current topics in microbiology and immunology.

[58]  G. Ada,et al.  The immune response to influenza infection. , 1986, Current topics in microbiology and immunology.

[59]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.

[60]  A. Allison,et al.  Immune responses to influenza virus in the mouse, and their role in control of the infection. , 1979, British medical bulletin.

[61]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.

[62]  Y. S. Shvartsman,et al.  Secretory anti-influenza immunity. , 1976, Advances in immunology.

[63]  H. B. Kaltreider Expression of immune mechanisms in the lung. , 1976, The American review of respiratory disease.